巨细胞动脉炎的血浆蛋白质组分析
该多机构前瞻性纵向研究对30例巨细胞动脉炎(GCA)患者活动期与临床缓解期血浆及30名年龄、性别、种族匹配的非疾病对照进行高通量适配体蛋白质组检测,发现活动期与对照间537种蛋白差异丰富、缓解期与对照间781种,16种蛋白与活动期疾病活动度相关;随机森林模型区分活动期和缓解期GCA与对照的10折交叉验证准确率分别为95.0%和98.3%,但血浆蛋白单独区分同一患者活动与缓解状态能力有限。
要点
- 活动期GCA与对照间鉴定出537种差异丰富蛋白,缓解期GCA与对照间781种。
- 16种血浆蛋白与活动期GCA患者疾病活动度相关。
- 随机森林模型10折交叉验证区分活动期和缓解期GCA与对照的准确率分别为95.0%和98.3%。
核心结论
- GCA血浆蛋白质组综合分析提示,血液蛋白特征结合机器学习有望发现GCA的多重生物标志物。
研究设计与样本
- 多机构前瞻性纵向研究,纳入30例GCA患者(活动期和临床缓解期各采集一次血浆)及30名年龄、性别、种族匹配的非疾病对照。
- 采用基于适配体的高通量蛋白质组学检测,覆盖超过7000种蛋白特征。
主要发现
- 校正潜在混杂因素后,活动期GCA与对照间537种蛋白差异丰富,缓解期GCA与对照间781种蛋白差异丰富。
- 这些蛋白提示各疾病状态涉及不同的免疫应答、代谢通路及潜在的新生理过程。
- 16种蛋白与活动期GCA患者疾病活动度相关。
- 基于血浆蛋白质组训练的随机森林模型在10折交叉验证中区分活动期和缓解期GCA与对照的准确率分别为95.0%和98.3%。
- 血浆蛋白单独区分同一患者活动期与缓解期的能力有限。
局限性
- 血浆蛋白单独区分同一患者活动期与缓解期疾病状态的能力有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: This study aimed to identify plasma proteomic signatures that differentiate active and inactive giant cell arteritis (GCA) from non-disease controls. By comprehensively profiling the plasma proteome of both patients with GCA and controls, we aimed to identify plasma proteins that (1) distinguish patients from controls and (2) associate with disease activity in GCA. METHODS: Plasma samples were obtained from 30 patients with GCA in a multi-institutional, prospective longitudinal study: one captured during active disease and another while in clinical remission. Samples from 30 age-matched/sex-matched/race-matched non-disease controls were also collected. A high-throughput, aptamer-based proteomics assay, which examines over 7000 protein features, was used to generate plasma proteome profiles from study participants. RESULTS: After adjusting for potential confounders, we identified 537 proteins differentially abundant between active GCA and controls, and 781 between inactive GCA and controls. These proteins suggest distinct immune responses, metabolic pathways and potentially novel physiological processes involved in each disease state. Additionally, we found 16 proteins associated with disease activity in patients with active GCA. Random forest models trained on the plasma proteome profiles accurately differentiated active and inactive GCA groups from controls (95.0% and 98.3% in 10-fold cross-validation, respectively). However, plasma proteins alone provided limited ability to distinguish between active and inactive disease states within the same patients. CONCLUSIONS: This comprehensive analysis of the plasma proteome in GCA suggests that blood protein signatures integrated with machine learning hold promise for discovering multiplex biomarkers for GCA.
引用
- Cunningham KY, Hur B, Gupta VK, et al. Plasma proteome profiling in giant cell arteritis. Ann Rheum Dis. 2024. PMID: 39153834. doi:10.1136/ard-2024-225868
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。